⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockIsraelNYSE

TEVA

Teva Pharmaceutical Industries Limited

Healthcare · Drug Manufacturers - Specialty & Generic

39.41USD

-0.8000 (-1.99%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TEVA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 39.41
P/E65.1
Dvd Ind Yld0.0%
P/B5.93
P/S3.3
Curr EV/T12M EBITDA22.8
Mkt Cap (USD)46.0B
Curr EV (USD)59.2B
2)

Per Share Data

EPS T12M0.60
DPS0.01
Bk Val Per Sh6.65
Rev/Sh12.11
Cash/Sh3.14
Curr Shares Out1,166.3M
FCF/Sh1.16
3)

Cash Flow Analysis

P/CF24.2
Curr P/FCF34.1
CF/NI2.7
Dvd P/O1.7%
Cash Gen/Cash Reqd3.4
Csh Dvd Cov158.2
CFO/Sales13.5%
Eff Interest Rate36.9%
4)

Growth Potential

Dil EPS 1Y Gr183.4%
Cap 1Y Gr36.0%
BPS 1Y Gr43.2%
R&D To Sales0.7%
Retention Rate98.3%
Rev 1Y Gr4.3%
FCF 1Y Gr53.3%
Assets 1Y Gr3.6%
5)

Profitability

EBITDA2.6B
EBIT1.6B
Operating Margin11.4%
Pretax Margin5.0%
Net Margin5.0%
ROA1.8%
ROE9.7%
ROC3.8%
Asset Turnover0.35
6)

Structure

Current Ratio0.88
Quick Ratio0.46
Debt/Assets83.6%
Debt/Com Eq429.9%
Net Debt/EBITDA11.45
Tot Debt/Capital81.1%
Gross Margin64.4%
EBIT/Int Exp1.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.